What is the recommended usage and dosage of Dextran 70-hypromellose solution?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Dextran 70-Hypromellose Ophthalmic Solution

Recommended Usage and Dosage

Instill one or two drops in the affected eye(s) as needed for symptomatic relief of dry eye symptoms. 1

Active Ingredients

The FDA-approved formulation contains:

  • Dextran 70: 0.1% 1
  • Hypromellose: 0.3% 1

Clinical Indications

This combination artificial tear solution is indicated for:

  • Symptomatic relief of dry eye disease 2, 3
  • Post-operative dry eye following cataract surgery 3
  • Ocular surface lubrication and protection 2

Dosing Frequency

  • Apply as needed throughout the day based on symptom severity 1
  • No maximum daily dose is specified in FDA labeling, allowing flexible use based on patient symptoms 1
  • Patients typically use 1-2 drops per affected eye multiple times daily 2

Clinical Efficacy Evidence

Comparative Effectiveness

  • Both preserved and preservative-free formulations demonstrate equivalent efficacy in improving OSDI scores, conjunctival staining, and corneal staining scores after 4 weeks of use 2
  • Dextran-70 eye drops are less effective than sodium hyaluronate or polyethylene glycol for post-phacoemulsification dry eye, with higher incidence of persistent dry eye symptoms (39.39% vs 12.12% and 18.18% respectively) 3
  • Tear breakup time, corneal staining scores, and Schirmer I test results are inferior with dextran-70 compared to sodium hyaluronate or polyethylene glycol at all time points from 3 to 60 days post-operatively 3

Formulation Considerations

Preservative-Free vs Preserved

  • Preservative-free single-dose formulations contain dextran 70 1mg/ml and hypromellose 3mg/ml 2
  • Multi-dose preserved formulations contain 0.3g hypromellose and 0.1g dextran 70 with 0.01% benzalkonium chloride (BAK) 2
  • Both formulations show statistically equivalent improvements in dry eye parameters, though preservative-free may be preferred for patients with BAK sensitivity 2

Clinical Pitfalls and Caveats

  • Consider alternative agents for post-surgical dry eye: Sodium hyaluronate or polyethylene glycol demonstrate superior outcomes compared to dextran-70 formulations in the post-phacoemulsification setting 3
  • No improvement in tear production: Schirmer test scores do not significantly improve with dextran-70/hypromellose treatment, indicating this is primarily a lubricant rather than a tear secretagogue 2
  • Symptom-based dosing: Since no maximum frequency is specified, patients should be counseled to use as frequently as needed for comfort without concern for overdosing 1

Administration Technique

  • Instill drops directly onto the ocular surface 1
  • Avoid touching the dropper tip to any surface to prevent contamination 1
  • If using multiple ophthalmic medications, wait at least 5 minutes between different eye drop applications 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.